approval
saveMEKINIST (TRAMETINIB) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 198d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 198d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 537d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 551d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 551d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 19, 2025 · 570d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 570d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 582d ago
same company · ±60 days · 6
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 29, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 29, 2024
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMar 29, 2024
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 4, 2024
- approvalKESIMPTA: KESIMPTA (OFATUMUMAB) — FDA approvalApr 12, 2024
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024
comments(0)
5-min edit window · permanent after that